Dr. Andrew Zganjar, MD
What this data tells you about Dr. Zganjar
Dr. Andrew Zganjar is an urology physician in Jacksonville, FL, with 11 years in practice. Based on federal Medicare data, Dr. Zganjar performed 15,446 Medicare services across 799 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zganjar received a total of $1,997 from 12 pharmaceutical and/or device companies across 19 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zganjar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 8,701 | $2 | $18 |
| Injection, docetaxel, 1 mg | 4,449 | $1 | $9 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 1,125 | $3 | $40 |
| Instillation of anti-cancer drug into bladder | 346 | $68 | $1,100 |
| Diagnostic exam of bladder and urethra using an endoscope | 148 | $182 | $1,004 |
| Office visit, established patient (20-29 min) | 108 | $70 | $296 |
| Imaging of urinary tract following injection of a contrast agent | 93 | $19 | $615 |
| New patient office visit (45-59 min) | 90 | $125 | $707 |
| Insertion of stent in ureter using an endoscope | 63 | $85 | $1,944 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | 52 | $213 | $1,936 |
| Office visit, established patient (30-39 min) | 31 | $95 | $450 |
| Injection, garamycin, gentamicin, up to 80 mg | 31 | $2 | $51 |
| Bladder ultrasound after voiding | 29 | $8 | $110 |
| New patient office visit (30-44 min) | 25 | $86 | $456 |
| New patient office visit, complex (60-74 min) | 25 | $175 | $891 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 22 | $319 | $3,767 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | 21 | $182 | $1,627 |
| Office visit, established patient, complex (40-54 min) | 20 | $129 | $604 |
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 17 | $963 | $9,760 |
| Diagnostic exam of bladder, urethra, and ureter or kidney using an endoscope | 15 | $229 | $2,367 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 13 | $235 | $1,407 |
| Other procedure on bladder using an endoscope | 11 | $1,426 | $20,957 |
| Destruction and/or removal of large growth of bladder using an endoscope | 11 | $302 | $3,770 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Zganjar is a mixed practice specialist, with above-average Medicare volume (top 8% in FL), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Zganjar experienced with bcg treatment for bladder cancer?
Does Dr. Zganjar receive payments from pharmaceutical companies?
How do Dr. Zganjar's costs compare to other urology physicians in Jacksonville?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology